dabigatran has been researched along with camostat in 2 studies
| Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) | Studies (camostat) | Trials (camostat) | Recent Studies (post-2010) (camostat) |
|---|---|---|---|---|---|
| 3,887 | 261 | 3,490 | 337 | 14 | 93 |
| Protein | Taxonomy | dabigatran (IC50) | camostat (IC50) |
|---|---|---|---|
| Transmembrane protease serine 2 | Homo sapiens (human) | 0.018 | |
| Prothrombin | Homo sapiens (human) | 0.399 | |
| Serine protease hepsin | Homo sapiens (human) | 0.0235 | |
| Trypsin-1 | Homo sapiens (human) | 0.0035 | |
| Trypsin-2 | Homo sapiens (human) | 0.0035 | |
| Procathepsin L | Homo sapiens (human) | 0.018 | |
| Furin | Homo sapiens (human) | 0.018 | |
| Trypsin-3 | Homo sapiens (human) | 0.0035 | |
| Transmembrane protease serine 6 | Homo sapiens (human) | 0.018 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 2.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Franco, FM; Han, Z; Harris, PK; Janetka, JW; Jarvis, CM; Jones, DE; Wildman, SA | 1 |
2 other study(ies) available for dabigatran and camostat
| Article | Year |
|---|---|
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
Topics: Amidines; Antineoplastic Agents; Arginine; Benzamidines; Catalytic Domain; Drug Design; Enzyme Assays; Guanidines; High-Throughput Screening Assays; Humans; Kinetics; Molecular Docking Simulation; Neoplasm Proteins; Peptidomimetics; Phenylalanine; Piperazines; Protease Inhibitors; Recombinant Proteins; Serine Endopeptidases; Structure-Activity Relationship; Urea | 2015 |